Covid-19: AstraZeneca may expose vaccine trial participants to virus
Team Udayavani, May 29, 2020, 12:24 PM IST
AstraZeneca is developing a leading coronavirus vaccine with Oxford University and has started phase 2 and 3 trials of the vaccine.
Now, the chief executive says although it is too early to deliberately expose vaccine trial participants to the pathogen, it may become an option.
AstraZeneca is looking to recruit around 10,000 adults and children in Britain and a few of the participants will have to become infected in the course of their normal lives to achieve a reliable reading from the study over the next few months.
Pascal Soriot, CEO, AstraZeneca, said, “We are running against time. We are seeing already in Europe the disease is declining. Very soon the disease intensity will be low, and it will become difficult, so we have to move very quickly”
“If the disease gets to a very low level, maybe challenge studies will have to be considered. But we felt it’s too early today to do that”, he added
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Low back pain, depression, headaches main causes of poor health: Study
Surgical options for Parkinson’s disease
Breast cancer to cause a million deaths a year by 2040: Lancet commission
Will to resist temptations, achieve goals more trustworthy than using apps, study finds
Govt directs e-commerce firms to remove drinks, beverages from ‘health drinks’ category
MUST WATCH
Latest Additions
President Murmu expresses deep concern over loss of lives in Odisha boat tragedy
VHP urges NIA probe into murder of Hubballi college student
Modi’s vision to make India a developed nation in 2024 overshadowed by the corruption of those in power
Hegde condemns Neha’s murder, demands justice
Kerala CM accuses UDF MPs of neglecting state’s interests in Parliament